Provectus Biopharmaceuticals (PVCT) Liabilities and Shareholders Equity (2010 - 2026)
Provectus Biopharmaceuticals' Liabilities and Shareholders Equity came in at $1.47 million for Q2 2026, up 104.0% from $722,384 a year earlier.
Powered by 
Analysis
Provectus Biopharmaceuticals (PVCT) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Provectus Biopharmaceuticals' Liabilities and Shareholders Equity was $697,502, down 30.7% from FY2024.
- Liabilities and Shareholders Equity has declined in each of the last four years, though with a five-year compound annual growth rate of 3.4% (FY2020 to FY2025).
- Going back by year, Liabilities and Shareholders Equity was $1.01 million in FY2024 (-30.5%), $1.45 million in FY2023 (-28.9%), $2.04 million in FY2022 (-42.0%) and $3.51 million in FY2021 (+496.3%).
- The Q2 2026 figure represents the highest quarterly Liabilities and Shareholders Equity since Q3 2023.
- Year-over-year, Liabilities and Shareholders Equity increased in 1 of the last seven quarters, with an average decline of 15.9%.
- The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q4 2021 (growth of 496.3%), and the weakest in Q3 2021 (a decline of 55.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - | 1.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.47 Mn |
| Dec 31, 2025 | 697,502.00 |
| Sep 30, 2025 | 419,904.00 |
| Jun 30, 2025 | 722,384.00 |
| Mar 31, 2025 | 666,257.00 |
| Dec 31, 2024 | 1.01 Mn |
| Sep 30, 2024 | 802,033.00 |
| Jun 30, 2024 | 856,427.00 |
| Mar 31, 2024 | 1.08 Mn |
| Dec 31, 2023 | 1.45 Mn |
| Sep 30, 2023 | 1.69 Mn |
| Jun 30, 2023 | 1.69 Mn |
| Mar 31, 2023 | 1.72 Mn |
| Dec 31, 2022 | 2.04 Mn |
| Sep 30, 2022 | 2.05 Mn |
| Jun 30, 2022 | 2.44 Mn |
| Mar 31, 2022 | 2.76 Mn |
| Dec 31, 2021 | 3.51 Mn |
| Sep 30, 2021 | 600,336.00 |
| Jun 30, 2021 | 466,299.00 |
API Access
Provectus Biopharmaceuticals Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=PVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();